Bahl & Gaynor Inc. lessened its holdings in shares of HealthSouth Corporation (NYSE:HLS) by 22.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,975 shares of the company’s stock after selling 6,675 shares during the period. Bahl & Gaynor Inc.’s holdings in HealthSouth Corporation were worth $947,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of HLS. Great West Life Assurance Co. Can raised its position in shares of HealthSouth Corporation by 1.9% during the 1st quarter. Great West Life Assurance Co. Can now owns 51,663 shares of the company’s stock worth $2,211,000 after acquiring an additional 958 shares in the last quarter. First Trust Advisors LP raised its position in shares of HealthSouth Corporation by 39.9% during the 1st quarter. First Trust Advisors LP now owns 70,779 shares of the company’s stock worth $3,030,000 after acquiring an additional 20,194 shares in the last quarter. Advisors Asset Management Inc. raised its position in shares of HealthSouth Corporation by 86.1% during the 1st quarter. Advisors Asset Management Inc. now owns 13,083 shares of the company’s stock worth $560,000 after acquiring an additional 6,052 shares in the last quarter. LS Investment Advisors LLC raised its position in shares of HealthSouth Corporation by 17.9% during the 1st quarter. LS Investment Advisors LLC now owns 7,799 shares of the company’s stock worth $334,000 after acquiring an additional 1,183 shares in the last quarter. Finally, Swiss National Bank raised its position in shares of HealthSouth Corporation by 0.6% during the 1st quarter. Swiss National Bank now owns 148,500 shares of the company’s stock worth $6,357,000 after acquiring an additional 900 shares in the last quarter. 93.10% of the stock is currently owned by institutional investors and hedge funds.
HealthSouth Corporation (HLS) opened at 44.94 on Friday. The company’s 50-day moving average price is $44.19 and its 200-day moving average price is $44.89. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $49.71. The stock has a market cap of $4.44 billion, a P/E ratio of 15.82 and a beta of 0.59.
HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings data on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The firm had revenue of $981.30 million for the quarter, compared to analysts’ expectations of $976.46 million. During the same quarter in the prior year, the firm posted $0.69 earnings per share. HealthSouth Corporation’s revenue for the quarter was up 6.6% compared to the same quarter last year. Analysts predict that HealthSouth Corporation will post $2.71 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be paid a dividend of $0.25 per share. The ex-dividend date is Friday, September 29th. This represents a $1.00 annualized dividend and a yield of 2.23%. This is a boost from HealthSouth Corporation’s previous quarterly dividend of $0.24. HealthSouth Corporation’s dividend payout ratio is presently 35.29%.
A number of research analysts recently issued reports on HLS shares. Zacks Investment Research upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $55.00 price target on the stock in a research note on Thursday, June 29th. Royal Bank Of Canada restated a “buy” rating and set a $53.00 price target on shares of HealthSouth Corporation in a research note on Wednesday, July 5th. KeyCorp started coverage on HealthSouth Corporation in a research note on Thursday, June 15th. They set a “sector weight” rating on the stock. Mizuho raised their price target on HealthSouth Corporation from $44.00 to $47.00 and gave the stock a “neutral” rating in a research note on Monday, July 10th. Finally, BidaskClub upgraded HealthSouth Corporation from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the stock. HealthSouth Corporation has an average rating of “Hold” and an average price target of $49.71.
TRADEMARK VIOLATION NOTICE: This article was posted by Equities Focus and is the property of of Equities Focus. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.equitiesfocus.com/2017/09/17/healthsouth-corporation-hls-shares-sold-by-bahl-gaynor-inc.html.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the sale, the chief executive officer now owns 283,134 shares in the company, valued at $12,174,762. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.60% of the company’s stock.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.